2022
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
Al’Aref S, Altibi A, Malkawi A, Mansour M, Baskaran L, Masri A, Rahmouni H, Abete R, Andreini D, Aquaro G, Barison A, Bogaert J, Camastra G, Carigi S, Carrabba N, Casavecchia G, Censi S, Cicala G, Conte E, De Cecco C, De Lazzari M, Di Giovine G, Di Roma M, Dobrovie M, Focardi M, Gaibazzi N, Gismondi A, Gravina M, Guglielmo M, Lanzillo C, Lombardi M, Lorenzoni V, Lozano-Torres J, Margonato D, Martini C, Marzo F, Masci P, Masi A, Memeo R, Moro C, Mushtaq S, Nese A, Palumbo A, Pavon A, Pedrotti P, Pepi M, Marra M, Pica S, Pradella S, Presicci C, Rabbat M, Raineri C, Rodriguez-Palomares J, Sbarbati S, Schoepf U, Squeri A, Sverzellati N, Symons R, Tat E, Timpani M, Todiere G, Valentini A, Varga-Szemes A, Volpe A, Fusini L, Guaricci A, Schwitter J, Pontone G. Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy. European Heart Journal - Cardiovascular Imaging 2022, 24: 472-482. PMID: 35792682, PMCID: PMC10029842, DOI: 10.1093/ehjci/jeac124.Peer-Reviewed Original ResearchConceptsRight ventricular systolic dysfunctionCardiac magnetic resonanceAll-cause mortalityPredictor of all-cause mortalityRV ejection fractionPrognostic valueEjection fractionSystolic dysfunctionHeart failureQuantitative assessment of RV functionMean left ventricular ejection fractionAssessment of RV functionBaseline cardiac magnetic resonanceRV systolic dysfunctionRV systolic functionMedian follow-upNormal renal functionVentricular systolic dysfunctionVentricular ejection fractionReduced ejection fractionKaplan-Meier curvesRV functionNYHA III/IVSystolic functionRenal dysfunction
2021
Characteristics and comparative clinical outcomes of prisoner versus non-prisoner populations hospitalized with COVID-19
Altibi A, Pallavi B, Liaqat H, Slota A, Sheth R, Al Jebbawi L, George M, LeDuc A, Abdallah E, Russell L, Jain S, Shirvanian N, Masri A, Kak V. Characteristics and comparative clinical outcomes of prisoner versus non-prisoner populations hospitalized with COVID-19. Scientific Reports 2021, 11: 6488. PMID: 33753786, PMCID: PMC7985211, DOI: 10.1038/s41598-021-85916-w.Peer-Reviewed Original ResearchConceptsPrisoner statusNon-prisonersOutcomes of prisonersNon-prison populationIn-hospital mortalityIntensive care unitCOVID-19 patientsIncarcerated individualsClinical outcomesHospitalized prisonersPrisonPrimary outcomeCohort of hospitalized COVID-19 patientsCompare clinical outcomesElevated inflammatory markersHospitalized COVID-19 patientsRates of ICU admissionSevere clinical presentationCox regression modelsAssociated with more severe clinical presentationIn-hospital deathAssociated with higher in-hospital deathMultivariate logistic regressionHigher in-hospital deathCOVID-19Spontaneous Biliary Pericardial Tamponade: A Case Report and Literature Review
Battisha A, Altibi A, Madoukh B, Sheikh O, Sawalha K, Shaikh S, Al-Sadawi M. Spontaneous Biliary Pericardial Tamponade: A Case Report and Literature Review. Current Cardiology Reviews 2021, 17: 204-208. PMID: 32525780, PMCID: PMC8226206, DOI: 10.2174/1573403x16666200611132045.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedBiliary Tract DiseasesCardiac TamponadeDyspneaFemaleHumansMaleMiddle AgedPericardiocentesisConceptsPericardial tamponadeRare formPericardial spacePotential fistulaPericardial fluidPresence of associated malignancyChest wall traumaPericardial injuryCardiac tamponadeHIDA scanAbdominal surgeryDetecting fistulasCase reportTamponadeChest surgeryFistulaIncreased riskBiliary systemHepatobiliary systemWorkupNon-revealingHispanic malesPericardiocentesisSurgeryMale
2020
Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes
Battisha A, Sawalha K, Altibi A, Madoukh B, Al-Akchar M, Patel B. Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes. Heart Failure Reviews 2020, 27: 93-101. PMID: 32562022, DOI: 10.1007/s10741-020-09990-4.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusCoronary artery diseaseGiant cell arteritisCardiogenic shockTakayasu arteritisRheumatologic conditionsAntiphospholipid syndromeEosinophilic myocarditisRheumatoid arthritisRheumatologic diseasesHigh-dose steroidsAssociated with cardiogenic shockAutoimmune rheumatologic diseasesAutoimmune rheumatologic disordersCardiogenic shock patientsSystematic literature searchImmunosuppressive therapyShock patientsHeart transplantationLupus erythematosusRheumatologic disordersMean ageArtery diseaseIncreased riskWeb of ScienceThe Utility of Intraoperative Lateral Spread Recording in Microvascular Decompression for Hemifacial Spasm: A Systematic Review and Meta-Analysis.
Thirumala P, Altibi A, Chang R, Saca E, Iyengar P, Reddy R, Anetakis K, Crammond D, Balzer J, Sekula R. The Utility of Intraoperative Lateral Spread Recording in Microvascular Decompression for Hemifacial Spasm: A Systematic Review and Meta-Analysis. Neurosurgery 2020, 87: e473-e484. PMID: 32297629, DOI: 10.1093/neuros/nyaa069.Peer-Reviewed Original ResearchConceptsLateral spread responseSpasm-free statusMicrovascular decompressionHemifacial spasmIntraoperative LSR monitoringClinical outcome of microvascular decompressionPersistence of lateral spread responseCranial nervesAbnormal lateral spread responseIntraoperative lateral spread responseLateral spread response monitoringResponse to facial nerve stimulationOutcome of microvascular decompressionAdequacy of decompressionFacial nerve stimulationMeta-analysisDiagnostic odds ratioPositive predictive valueSurgical treatmentClinical outcomesNerve stimulationOdds ratioWeb of ScienceHigh riskPredictive value
2019
Native valve endocarditis caused by ErysipelothrixRhusiopathiae: presenting with refractory heart failure and requiring surgical valve replacement—report on a rare zoonosis
Altibi A, Khalid M, Kak V, Patel B. Native valve endocarditis caused by ErysipelothrixRhusiopathiae: presenting with refractory heart failure and requiring surgical valve replacement—report on a rare zoonosis. BMJ Case Reports 2019, 12: e230891. PMID: 31862813, PMCID: PMC6936573, DOI: 10.1136/bcr-2019-230891.Peer-Reviewed Original ResearchConceptsSevere acute aortic regurgitationInitiation of antimicrobial treatmentNative valve endocarditisLack of feverAcute aortic regurgitationRefractory heart failureSurgical valve replacementValve endocarditisAortic regurgitationValve replacementMale patientsCutaneous manifestationsGram-positive bacillusDifferential diagnosisHeart failureClinical dataAntimicrobial treatmentCutaneous lesionsSystemic infectionBacteraemiaMedical managementClinical meritRare zoonosisOccupational exposureClinical settingIntroduction of Novel Surgical Techniques: A Survey on Knowledge, Attitude, and Practice of Surgeons
Ahmed A, Giang H, Ghozy S, Salem H, Algazar M, Altibi A, Son H, Anh T, Cuong T, Tuan L, Vuong N, Abdou M, Ghorab M, Tran N, Elawady S, Elmaraezy A, Minh L, Hirayama K, Huy N. Introduction of Novel Surgical Techniques: A Survey on Knowledge, Attitude, and Practice of Surgeons. Surgical Innovation 2019, 26: 560-572. PMID: 31130082, DOI: 10.1177/1553350619849127.Peer-Reviewed Original ResearchConceptsNovel surgical techniqueSurgical techniquePractice of surgeonsEvidence-based guidelinesLevel of educationLength of lifeModern surgical careSurgical careTraining programMeta-analysesSurgeon experienceJunior surgeonsResponse rateCareSurgeonsEvent ratesPatientsAttitudesPracticeSurveyDeveloping worldPractical questionsWearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis
Masri A, Altibi A, Erqou S, Zmaili M, Saleh A, Al-Adham R, Ayoub K, Baghal M, Alkukhun L, Barakat A, Jain S, Saba S, Adelstein E. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis. JACC Clinical Electrophysiology 2019, 5: 152-161. PMID: 30784684, PMCID: PMC6383782, DOI: 10.1016/j.jacep.2018.11.011.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsWearable cardioverter-defibrillator therapyWearable cardioverter-defibrillatorVEST trialSudden cardiac deathDerSimonian and Laird methodCardiac deathMonths of follow-upPrevention of sudden cardiac deathA systematic reviewPrimary preventionOutcomes of patientsCardioverter-defibrillator therapyLaird methodObservational studyMeta-analysisGoogle ScholarIschemic cardiomyopathyMedical therapyFollow-upCardioverter-defibrillatorPreventionTherapyVestPersons
2017
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis
Vuong H, Altibi A, Duong U, Ngo H, Pham T, Tran H, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R, Kondo T. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis. Tumor Biology 2017, 39: 1010428317713913. PMID: 29037127, DOI: 10.1177/1010428317713913.Peer-Reviewed Original ResearchConceptsPapillary thyroid cancerTERT promoter mutationsDistant metastasisThyroid cancerPromoter mutationsRET/PTC rearrangementsBRAF mutationsPresence of distant metastasesAssessment of patient prognosisTumor risk stratificationAssociated with distant metastasisPapillary thyroid carcinomaMeta-analysisPredicting distant metastasisAssociation of BRAFRandom-effects modelThyroid carcinomaTERT promoterRisk stratificationPatient prognosisRAS mutationsAdverse outcomesMetastasisIncreased riskBRAF
2016
The changing characteristics and molecular profiles of papillary thyroid carcinoma over time - a systematic review
Vuong H, Altibi A, Abdelhamid A, Ngoc P, Quan V, Tantawi M, Elfil M, Le Huy Vu T, Elgebaly A, Oishi N, Nakazawa T, Hirayama K, Katoh R, Huy N, Kondo T. The changing characteristics and molecular profiles of papillary thyroid carcinoma over time - a systematic review. Oncotarget 2016, 5: 10637-10649. PMID: 27793009, PMCID: PMC5354688, DOI: 10.18632/oncotarget.12885.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkers, TumorCarcinoma, PapillaryChi-Square DistributionFemaleGene RearrangementGenes, rasGenetic Predisposition to DiseaseHumansMaleMiddle AgedMutationPhenotypeProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-retRisk FactorsThyroid Cancer, PapillaryThyroid NeoplasmsTime FactorsTranscriptomeConceptsPapillary thyroid carcinomaMolecular profilingThyroid carcinomaClinicopathological featuresGenetic alterationsRisk factors of thyroid cancerPapillary thyroid carcinoma patientsSystematic reviewSurgical time periodStudent's t-testTumorigenesis of papillary thyroid carcinomaRET/PTC rearrangementsModification of patientsPearson chi-squareTeam of reviewersClinicopathological characteristicsPTC patientsBRAF mutationsThyroid cancerRAS mutationsScreened titlesRisk factorsInclusion criteriaElectronic databasesPotential articles